1. Hanrahan, EO, Gonzalez-Angulo, AM, Giordano, SH, et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 2007; 25: 4952–4960.
Google Scholar | Crossref | Medline2. Ignatov, T, Eggemann, H, Burger, E, et al. Management of small T1a/b breast cancer by tumor subtype. Breast Cancer Res Treat 2017; 163: 111–118.
Google Scholar | Crossref | Medline3. Badve SS, Beitsch PD, Bose S, et al. Part XI, Breast. In: Amin MB, Edge S, Greene F, et al. (eds). AJCC cancer staging manual . 8th edition. [ISBN: 978-3-319-40617-6]. Cham: Springer International Publishing, 2017.
Google Scholar4. Coates, AS, Winer, EP, Goldhirsch, A, et al. Tailoring therapies – improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015. Ann Oncol 2015; 26: 1533–1546.
Google Scholar | Crossref | Medline5. Hofvind, S, Tsuruda, K, Mangerud, G, et al. The Norwegian breast cancer screening program, 1996-2016: celebrating 20 years of organised mammographic screening. In: Cancer in Norway 2016 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway, 2017, pp.S1–S72.
Google Scholar6. Knutsvik, G, Stefansson, IM, Aziz, S, et al. Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. PLoS One 2014; 9: e112121.
Google Scholar | Crossref | Medline7. Kreftregisterforskriften , https://lovdata.no/dokument/SF/forskrift/2001-12-21-1477. Lovdata. March 2021 (accessed 29 May 2021).
Google Scholar8. Goldhirsch, A, Winer, EP, Coates, AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 2013; 24: 2206–2223.
Google Scholar | Crossref | Medline | ISI9. Larsen, IK, Smastuen, M, Johannesen, TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218–1231.
Google Scholar | Crossref | Medline | ISI10. Lydersen, SFM, Laake, P. Categorical data and contingency tables. In: Veierød, MB, Lydersen, S, Laake, P (eds) Medical statistics in clinical and epidemiological research. Oslo: Gyldendal Norsk Forlag, 2012, pp.48–89.
Google Scholar11. Tsuruda, KM, Hofvind, S, Akslen, LA, et al. Terminal digit preference: a source of measurement error in breast cancer diameter reporting. Acta Oncol 2020; 59: 260–267.
Google Scholar | Crossref | Medline12. Wallis, MG. How do we manage overdiagnosis/overtreatment in breast screening? Clin Radiol 2018; 73: 372–380.
Google Scholar | Crossref | Medline13. Marmot, MG, Altman, DG, Cameron, DA, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108: 2205–2240.
Google Scholar | Crossref | Medline | ISI14. Duffy, SW, Michalopoulos, D, Sebuodegard, S, et al. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution. J Med Screen 2014; 21: 24–29.
Google Scholar | SAGE Journals | ISI15. Puliti, D, Duffy, SW, Miccinesi, G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19: 42–56.
Google Scholar | SAGE Journals | ISI16. Sardanelli, F, Trimboli, RM, Tot, T. Expert review of breast pathology in borderline lesions: a chance to reduce overdiagnosis and overtreatment? JAMA Oncol 2018; 4: 1325–1326.
Google Scholar | Crossref | Medline17. Hersch, J, Barratt, A, Jansen, J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015; 385: 1642–1652.
Google Scholar | Crossref | Medline | ISI18. Sasieni, PD, Smith, RA, Duffy, SW. Informed decision-making and breast cancer screening. J Med Screen 2015; 22: 165–167.
Google Scholar | SAGE Journals | ISI